Search Results

There are 22177 results for: content related to: Use of α-blockers and the risk of hip/femur fractures

  1. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome

    BJU International

    Volume 110, Issue 7, October 2012, Pages: 1014–1022, Ammarin Thakkinstian, John Attia, Thunyarat Anothaisintawee and J. Curtis Nickel

    Article first published online : 3 APR 2012, DOI: 10.1111/j.1464-410X.2012.11088.x

  2. You have free access to this content
    Direct medical resource utilization associated with osteoporosis-related nonvertebral fractures in postmenopausal women

    Journal of Bone and Mineral Research

    Volume 28, Issue 2, February 2013, Pages: 360–371, Sonia Jean, Louis Bessette, Étienne L Belzile, K Shawn Davison, Bernard Candas, Suzanne Morin, Sylvie Dodin and Jacques P Brown

    Article first published online : 15 JAN 2013, DOI: 10.1002/jbmr.1756

  3. Effectiveness of Tumor Necrosis Factor α Blockers in Early Axial Spondyloarthritis: Data From the DESIR Cohort

    Arthritis & Rheumatology

    Volume 66, Issue 7, July 2014, Pages: 1734–1744, Anna Moltó, Simon Paternotte, Pascal Claudepierre, Maxime Breban and Maxime Dougados

    Article first published online : 27 JUN 2014, DOI: 10.1002/art.38613

  4. You have free access to this content
    Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case–control study

    Journal of Internal Medicine

    Volume 261, Issue 2, February 2007, Pages: 170–177, F. De Vries, S. Pouwels, J. W. J. Lammers, H. G. M. Leufkens, M. Bracke, C. Cooper and T. P. Van Staa

    Article first published online : 12 JAN 2007, DOI: 10.1111/j.1365-2796.2006.01754.x

  5. Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue 6, June 2007, Pages: 612–619, Frank de Vries, Sander Pouwels, Madelon Bracke, Hubert G.M. Leufkens, Cyrus Cooper, Jan-Willem J. Lammers and Tjeerd-Pieter van Staa

    Article first published online : 25 SEP 2006, DOI: 10.1002/pds.1318

  6. α-blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms

    BJU International

    Volume 101, Issue 3, February 2008, Pages: 319–324, Germar-M. Pinggera, Michael Mitterberger, Leo Pallwein, Antonius Schuster, Ralf Herwig, Ferdinand Frauscher, Georg Bartsch and Hannes Strasser

    Article first published online : 13 NOV 2007, DOI: 10.1111/j.1464-410X.2007.07339.x

  7. The role of nocturia in the quality of life of men with lower urinary tract symptoms

    BJU International

    Volume 105, Issue 8, April 2010, Pages: 1141–1146, Marleen M. Van Dijk, Hessel Wijkstra, Frans M. Debruyne, Jean J.M.C.H. De La Rosette and Martin C. Michel

    Article first published online : 26 OCT 2009, DOI: 10.1111/j.1464-410X.2009.08969.x

  8. You have full text access to this OnlineOpen article
    Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey

    International Journal of Clinical Practice

    Volume 62, Issue 1, January 2008, Pages: 18–26, M. Emberton, M. Marberger and J. De La Rosette

    Article first published online : 21 NOV 2007, DOI: 10.1111/j.1742-1241.2007.01635.x

  9. You have free access to this content
    α-Blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis

    BJU International

    Volume 106, Issue 2, July 2010, Pages: 256–261, Yefang Zhu, Diederick Duijvesz, Maroeska M. Rovers and Tycho M. Lock

    Article first published online : 4 NOV 2009, DOI: 10.1111/j.1464-410X.2009.09014.x

  10. α-Blockers and lower urinary tract function: more than smooth muscle relaxation?

    BJU International

    Volume 86, Issue s2, October 2000, Pages: 23–30, M.C. Michel, R.F. Schäfers and M. Goepel

    Article first published online : 2 JAN 2002, DOI: 10.1046/j.1464-410X.2000.00094.x

  11. You have free access to this content
    Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies

    Journal of Internal Medicine

    Volume 260, Issue 4, October 2006, Pages: 350–362, M. WIENS, M. ETMINAN, S. S. GILL and B. TAKKOUCHE

    Article first published online : 29 AUG 2006, DOI: 10.1111/j.1365-2796.2006.01695.x

  12. Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort

    BJU International

    Volume 108, Issue 11, December 2011, Pages: 1894–1902, Alastair D. Lamb, Sarah L. Vowler, Richard Johnston, Nick Dunn and Oliver J. Wiseman

    Article first published online : 31 MAR 2011, DOI: 10.1111/j.1464-410X.2011.10170.x

  13. Abstracts of the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Lisbon, Portugal, 24–27 August 2006

    Pharmacoepidemiology and Drug Safety

    Volume 15, Issue S1, August 2006, Pages: S1–S316,

    Article first published online : 1 AUG 2006, DOI: 10.1002/pds.1295

  14. A retrospective study of clinical outcomes of α-blocker or finasteride monotherapy followed by combination therapy: determination of the period of combination therapy of α-blocker and finasteride

    International Journal of Clinical Practice

    Volume 67, Issue 4, April 2013, Pages: 351–355, H. Son, S. Y. Cho, S. Park, J. Y. Kang, C. S. Kim and H. G. Kim

    Article first published online : 24 MAR 2013, DOI: 10.1111/ijcp.12045

  15. Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration

    BJU International

    Volume 106, Issue 9, November 2010, Pages: 1332–1338, Christopher R. Chapple, Sender Herschorn, Paul Abrams, Joseph T. Wang, Marina Brodsky and Zhonghong Guan

    Article first published online : 24 MAY 2010, DOI: 10.1111/j.1464-410X.2010.09359.x

  16. Current role of α-blockers in the treatment of benign prostatic hyperplasia

    BJU International

    Volume 102, Issue s2, November 2008, Pages: 3–7, Steven A. Kaplan

    Article first published online : 10 OCT 2008, DOI: 10.1111/j.1464-410X.2008.08086.x

  17. You have free access to this content
    Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction

    International Journal of Clinical Practice

    Volume 64, Issue 10, September 2010, Pages: 1425–1435, M. Emberton

    Article first published online : 22 JUN 2010, DOI: 10.1111/j.1742-1241.2010.02463.x

  18. Tumour necrosis factor-α blockers in the treatment of psoriasis

    British Journal of Dermatology

    Volume 162, Issue 6, June 2010, Pages: 1169–1171, M. Lebwohl

    Article first published online : 20 MAY 2010, DOI: 10.1111/j.1365-2133.2010.09835.x

  19. Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome

    BJU International

    Volume 106, Issue 9, November 2010, Pages: 1252–1263, J. Curtis Nickel and Daniel A. Shoskes

    Article first published online : 14 OCT 2010, DOI: 10.1111/j.1464-410X.2010.09701.x

  20. You have free access to this content
    Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea

    International Journal of Urology

    Volume 21, Issue 7, July 2014, Pages: 670–675, Masayuki Takeda, Osamu Yokoyama, Sung Won Lee, Masahiro Murakami, Yoji Morisaki and Lars Viktrup

    Article first published online : 27 FEB 2014, DOI: 10.1111/iju.12410